You are on page 1of 1

The Moon Shots Program

The University of Texas M.D. Anderson Cancer Center launched an ambitious e ort to dramatically reduce deaths from eight common and di cult cancers. Targeted cancers, with new U.S. cases and deaths in 2012:

Lung cancer
1 New cases: 226,160 1 Deaths: 160,340 1 Synopsis: Chemotherapy has been the main treatment since 1970s; M.D. Anderson will examine targeted oral therapies.

Triple negative breast cancer


1 New cases: 68,718 1 Deaths: 11,976 1 Synopsis: Treatment remains a challenge despite great strides in treating other breast cancers. Molecular course of disease similar to ovarian cancer; treatments are converging.

Prostate cancer
1 New cases: 241,740 1 Deaths: 28,170 1 Synopsis: A slow-growing cancer; research will standardize criteria for when treatment is needed and distinguish a lethal cancer from a less dangerous one.

Ovarian cancer (high-grade, serious variety)


1 New cases: 15,596 1 Deaths: 12,750 1 Synopsis: Many patients develop resistance to drugs; high recurrence rates. M.D. Anderson primed to establish rst standard screening.

Melanoma
1 New cases: 81,240 1 Deaths: 12,190 1 Synopsis: One of the most aggressive forms of skin cancer, its incidence has increased over 600 percent since 1950s; leading cause of cancer death in young women. The program will include public education, sun-safety programs and develop personalized treatments.

Acute myeloid Myelodysplastic leukemia (AML) syndrome


1 New cases: 13,780 1 Deaths: 10,200 1 Synopsis: AML marked by diminishing returns once patient stops responding to therapy; team will work on strategies to prevent relapse after stem cell transplant. 1 New cases: Estimates from 14,000 to 45,000 1 Synopsis: A marrow disease that may be caused by exposure to carcinogens, radiation or chemotherapy. Progresses to AML in 30 percent to 50 percent of cases.

Chronic lymphocytic leukemia (CLL)


1 New cases: 16,060 1 Deaths: 4,580 1 Synopsis: CLL is most common adult leukemia in the U.S.; research will seek to replace chemotherapy with new oral, less toxic treatments and rebuild immune system.

Sources: The University of Texas M.D. Anderson Cancer Center; American Cancer Society

Houston Chronicle

You might also like